none 10.31254/phyto.2024.13403 BioMed Research Publishers BioMed Research Publishers 16195 164950407 316921 20240922112415285 10.31254 2024-09-22T11:24:23Z 2024-09-22T11:24:21Z 1 The Journal of Phytopharmacology J Phytopharmacol 2320480X 10.31254/phyto https://www.phytopharmajournal.com/ 8 31 2024 13 4 Mohd Mustafa Misba Naim Mudassir Alam Kashif Abbas Waleem Ahmad Neda Tufail Irfan Qadir Tantry Sidra Islam Hamda Khan Rizwan Ahmad Nazura Usmani Moinuddin Safia Habib Cervical cancer represents a substantial global health issue, standing as the third most prevalent cancer globally and the principal cause of cancer-associated mortality in women, with an uneven burden shouldered by less developed countries. Despite being the most preventable malignancy, with nearly all cases attributed to HPV infection, which has a lifetime cumulative risk of 80% through sexual transmission, cervical cancer remains a pressing issue. National cervical cytology screening programs have been implemented to identify cervical abnormalities, lesions, and early malignancies in eligible women. However, the utilization of screening techniques is declining, and due to resource constraints, screening schemes have not been adopted in less-developed economies. Several nations have embraced alternative screening techniques, such as Visual Inspection with Acetic Acid (VIA), which have shown impacts on mortality and morbidity rates. With the rising accessibility of efficacious HPV screening and self-testing, there will be a necessity to reconfigure existing cervical screening programs. Furthermore, preventative HPV vaccination is an integral part of the World Health Organization’s (WHO) Global Strategy to Expedite the Eradication of Cervical Cancer as a Public Health Issue, necessitating the restructuring of vaccination endeavors. This review article evaluates potential techniques for detecting precancerous lesions within the context of the WHO's 90-70-90 global policy for cervical cancer prevention and early diagnosis. The incidence and mortality rates are examined, highlighting the effectiveness of cervical cancer prevention efforts. 8 31 2024 286 293 1 10.31254/biomed-crossmark-policy www.biomedresearch.org false 10.31254/phyto.2024.13403 https://www.phytopharmajournal.com/assets/pdf_files/Vol13_Issue4_03.pdf